Shots:
- Stryker has signed a definitive agreement to initiate a tender offer for acquiring all the issued & outstanding shares of Inari Medical for $80 per share in cash, making it a total value of ~$4.9B
- Upon completion, Stryker will acquire remaining shares in a second-step merger at the same price. The deal is expected to close by Q1’25, pending customary conditions
- The acquisition adds Inari’s mechanical thrombectomy solutions for deep vein thrombosis & pulmonary embolism to Stryker’s neurovascular business, bolstering its position in the peripheral vascular segment, mainly in venous thromboembolism (VTE)
Ref: Stryker| Image: Inari Medical
Related News: Stryker Signs a Definitive Agreement to Acquire Vocera Communications for ~$3.09B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
